Gut health medtech Atmo Biosciences raises $9.6m to progress ingestible capsule |Malcolm Hebblewhite

Name: Gut health medtech Atmo Biosciences raises $9.6m to progress ingestible capsule |Malcolm Hebblewhite
Uploaded: Sep 30, 2021 AEST
Duration: 1 min 54 s
Description: Australian digital health manufacturer Atmo Biosciences has raised AUD 9.6 million and won the support of global pharmaceutical players to meet unmet clinical, consumer and medical device needs. Mr, Malcolm Hebblewhite, the CEO of Atmo Biosciences sh...

September 30, 2021 02:05 PM AEST

Team Kalkine Media

Author

Team Kalkine Media -
25187 Posts
Team Kalkine Media comprises of experts who understand various markets nuances and are enthusiastic and passionate to provide best possible offerings in the form of insights and stories. The team has rich experience of working across different market...

Australian digital health manufacturer Atmo Biosciences has raised AUD 9.6 million and won the support of global pharmaceutical players to meet unmet clinical, consumer and medical device needs. Mr, Malcolm Hebblewhite, the CEO of Atmo Biosciences shares the goals that they are eying after achieving such astounding success.